Activation of the Wnt/β-catenin signaling pathway was discovered in 20–35% of HCC cases, among which most are resulted by gene mutations of the key genes, including CTNNB1, AXIN, and APC [16,17,18]. The gene discussed is AXIN1; the disease is hepatocellular carcinoma.